Electrical Stimulation of the Quadriceps and Diaphragm in Critically Ill Patients
Critical Illness Myopathy, Respiration, Artificial
About this trial
This is an interventional treatment trial for Critical Illness Myopathy focused on measuring Electric Stimulation, Intensive Care Units, Mechanical Ventilation, Ventilator Weaning
Eligibility Criteria
Inclusion Criteria:
- Age of 18 years or more
- 24 hours of MV or more
Exclusion Criteria:
Hemodynamic instability, pregnancy, body mass index(BMI) >35 kg/m2, history of neuromuscular disease at admission, brain death, diseases with systemic vascular involvement, bone fractures, use of an internal or external fixator, skin lesions, end-stage cancer, use of pacemakers, spinal injuries, or inability to receive an Medical Research Council score because of the cognitive state.
Sites / Locations
- Hospital Universitário do Oeste do Paraná
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Active Comparator
No Intervention
Diaphragm Group (DG)
Quadriceps Group (QG)
Control Group (CG)
subjects who received conventional physical therapy once a day, plus a daily session of electrical stimulation in the diaphragm. Intervention: Electrical stimulation of the diaphragm.
subjects who also received conventional physical therapy once a day, plus a daily session of electrical stimulation in the quadriceps. Intervention: Electrical stimulation of the quadriceps.
subjects who received regular treatment, i.e., conventional physical therapy, which included gross motor therapy and respiratory therapy twice a day every day, including weekend, during their stay in the ICU.